One bout of endurance exercise does not change gene expression or proliferation in a C26 colon carcinoma in immunocompetent mice.
BALB/c mice
C26 colon carcinoma
Cancer
Exercise
Journal
Journal of cancer research and clinical oncology
ISSN: 1432-1335
Titre abrégé: J Cancer Res Clin Oncol
Pays: Germany
ID NLM: 7902060
Informations de publication
Date de publication:
Dec 2023
Dec 2023
Historique:
received:
24
07
2023
accepted:
26
09
2023
medline:
20
11
2023
pubmed:
16
10
2023
entrez:
15
10
2023
Statut:
ppublish
Résumé
Exercise typically reduces tumour growth, proliferation and improves outcomes. Many of these effects require exercise to change gene expression within a tumour, but whether exercise actually affects gene expression within a tumour has not been investigated yet. The aim of this study was, therefore, to find out whether one bout of endurance exercise alters gene expression and proliferation in a C26 carcinoma in immunocompetent mice. BALB/c were injected with C26 colon carcinoma cells. Once the tumours had formed, the mice either ran for 65 min with increasing intensity or rested before the tumour was dissected. The tumours were then analysed by RNA-Seq and stained for the proliferation marker KI67. One bout of running for 65 min did not systematically change gene expression in C26 carcinomas of BALB/c mice when compared to BALB/c mice that were rested. However, when analysed for sex, the expression of 17, mostly skeletal muscle-related genes was higher in the samples of the female mice taken post-exercise. Further histological analysis showed that this signal likely comes from the presence of muscle fibres from the panniculus carnosus muscle inside the tumours. Also, we found no differences in the positivity for the proliferation marker KI67 in the control and exercise C26 carcinomas. A bout of exercise did not systematically affect gene expression or proliferation in C26 carcinomas in immunocompetent BALB/c mice.
Identifiants
pubmed: 37840045
doi: 10.1007/s00432-023-05447-x
pii: 10.1007/s00432-023-05447-x
pmc: PMC10657308
doi:
Substances chimiques
Ki-67 Antigen
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
17361-17369Subventions
Organisme : Zukunft Gesundheit e.V.
ID : MFAG 20406
Organisme : AIRC
ID : IG 27007
Informations de copyright
© 2023. The Author(s).
Références
Nature. 2019 May;569(7757):503-508
pubmed: 31068700
Nat Commun. 2020 Jan 24;11(1):470
pubmed: 31980607
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
Cell Metab. 2018 Jan 9;27(1):237-251.e4
pubmed: 29320704
J Clin Oncol. 2006 Aug 1;24(22):3527-34
pubmed: 16822844
Integr Cancer Ther. 2020 Jan-Dec;19:1534735420917462
pubmed: 32476493
Med Sci Sports Exerc. 2014 Sep;46(9):1744-51
pubmed: 24633595
Cell. 2020 May 28;181(5):1112-1130.e16
pubmed: 32470399
Compr Physiol. 2018 Dec 13;9(1):165-205
pubmed: 30549018
Trends Cancer. 2022 Feb;8(2):110-122
pubmed: 34776398
Physiology (Bethesda). 2022 May 1;37(3):115-127
pubmed: 34779282
Trends Endocrinol Metab. 2023 Nov;34(11):749-763
pubmed: 37633799
Eur J Appl Physiol. 2021 Aug;121(8):2107-2124
pubmed: 33864493
Sports Med Open. 2020 Feb 10;6(1):11
pubmed: 32040782
J Anat. 2018 Jun 12;:
pubmed: 29893024
iScience. 2020 Apr 24;23(4):100978
pubmed: 32240949
Breast Cancer Res Treat. 2020 Aug;183(1):161-175
pubmed: 32572716
Cancer Discov. 2018 Nov;8(11):1458-1473
pubmed: 30185628
Cell Metab. 2018 Jan 9;27(1):10-21
pubmed: 29056514
JAMA. 2005 May 25;293(20):2479-86
pubmed: 15914748
Biol Sport. 2016 Dec;33(4):381-391
pubmed: 28090143
J Clin Oncol. 2011 Feb 20;29(6):726-32
pubmed: 21205749
Compr Physiol. 2015 Jan;5(1):1-15
pubmed: 25589262
Cancer Res. 2017 Sep 15;77(18):4894-4904
pubmed: 28887324
Nucleic Acids Res. 2009 Jul;37(Web Server issue):W305-11
pubmed: 19465376
Scand J Med Sci Sports. 2015 Dec;25 Suppl 3:1-72
pubmed: 26606383
J Cachexia Sarcopenia Muscle. 2022 Feb;13(1):648-661
pubmed: 34741441